Predominant Role of Bacterial Pneumonia as a Cause of Death in Pandemic Influenza: Implications for Pandemic Influenza Preparedness

Cited by (1,629)

Items 601–700 of 1,629

1. First influenza season after the 2009 pandemic influenza: characteristics of intensive care unit admissions in adults and children in Vall d'Hebron Hospital
   Garyphallia Poulakou, Jéssica Romualdo Souto, Joan Balcells, Marcos Pérez-Carrasco, César Laborda, Oriol Roca, Teresa Tórtola, Miquel Pujol, Mercedes Palomar, Jordi Rello · 2011 · Clinical Microbiology and Infection
2. The Impact of a Six‐Year Climate Anomaly on the “Spanish Flu” Pandemic and WWI
   Alexander More, Christopher P. Loveluck, Heather M. Clifford · 2020 · GeoHealth
3. Medical treatment of 55 patients with COVID-19 from seven cities in northeast China who fully recovered
   Lichao Fan, Huan Liu, Na Li, Chang Liu, Ye Gu, Yongyu Liu, Yu Chen · 2021 · Medicine
4. Effectiveness of Pneumococcal Conjugate Vaccination Against Virus-Associated Lower Respiratory Tract Infection Among Adults: A Case-Control Study
   Joseph A. Lewnard, Katia J. Bruxvoort, Vennis X. Hong, Lindsay R. Grant, Luis Jódar, Alejandro D. Cane, Bradford D. Gessner, Sara Yee Tartof · 2022 · The Journal of Infectious Diseases
5. Lianhuaqingwen capsule inhibits non-lethal doses of influenza virus-induced secondary Staphylococcus aureus infection in mice
   Jian Song, Jin Zhao, Xuejun Cai, Shengle Qin, Zexin Chen, Xiaodong Huang, Runfeng Li, Yutao Wang, Xinhua Wang · 2022 · Journal of Ethnopharmacology
6. The health and economic impact of vaccination with 7-valent pneumococcal vaccine (PCV7) during an annual influenza epidemic and influenza pandemic in China
   Ronald Caldwell, Craig S. Roberts, Zhijie An, Chieh-I Chen, Bruce Wang · 2015 · BMC Infectious Diseases
7. Animal models in virus research: their utility and limitations
   Derrick Louz, Hans E. N. Bergmans, Birgit P. Loos, Rob C. Hoeben · 2012 · Critical Reviews in Microbiology
8. Effective protection against secondary pneumococcal pneumonia by oral vaccination with attenuated Salmonella delivering PspA antigen in mice
   Sang‐Uk Seo, Jae‐Jin Kim, Hyungjun Yang, Hyung-Joon Kwon, Jin‐Young Yang, Roy Curtiss, Mi‐Na Kweon · 2012 · Vaccine
9. Severe canine influenza in dogs correlates with hyperchemokinemia and high viral load
   Yuna Lee, Hyun‐Jeong Lee, Dong‐Hun Lee, Jung‐Hyun Kim, Hee‐Myung Park, Sang‐Soep Nahm, Joong‐Bok Lee, Seung‐Yong Park, In‐Soo Choi, Chang‐Seon Song · 2011 · Virology
10. Respiratory viral and pneumococcal coinfection of the respiratory tract: implications of pneumococcal vaccination
    David Paul Moore, Ron Dagan, Shabir Ahmed Madhi · 2012 · Expert Review of Respiratory Medicine
11. Effectiveness and safety of dual influenza and pneumococcal vaccination versus separate administration or no vaccination in older adults: a meta-analysis
    Mingjuan Yin, Lingfeng Huang, Yan Zhang, Na Li Yu, Xiaojia Xu, Yaping Liang, Jindong Ni · 2018 · Expert Review of Vaccines
12. Local memory CD4 T cell niches in respiratory viral infection
    K. Pruner, M. Pepper · 2021 · Journal of Experimental Medicine
13. Influenza Pandemics
    Ruth A. Elderfield, William Barclay · 2011 · Advances in experimental medicine and biology
14. Do multiple concurrent infections in African children cause irreversible immunological damage?
    Sarah J. Glennie, Moffat Nyirenda, Neil Williams, Robert S. Heyderman · 2011 · Immunology
15. Neutrophils: Neglected Players in Viral Diseases
    Christelle Gabriel, Zhisheng Her, Lisa F. P. Ng · 2013 · DNA and Cell Biology
16. The clinical outcome of COVID-19 is strongly associated with microbiome dynamics in the upper respiratory tract
    Linlin Xie, Gengyan Luo, Zhongzhou Yang, Wei-Chen Wu, Jin-tao Chen, Yuting Ren, Zhikun Zeng, Guangming Ye, Yunbao Pan, Wen-jing Zhao et al. · 2024 · Journal of Infection
17. Cell type–specific efferocytosis determines functional plasticity of alveolar macrophages
    Julian Better, Mohammad Estiri, Michael Wetstein, Learta Pervizaj-Oruqaj, Christina Malainou, Victoria K. Ogungbemi-Alt, Maximiliano Ruben Ferrero, Martin Langelage, Irina Kuznetsova, Ana Ivonne Vazquez‐Armendariz et al. · 2025 · Science Immunology
18. Dysregulated Macrophage-Inflammatory Protein-2 Expression Drives Illness in Bacterial Superinfection of Influenza
    Caleb C. J. Zavitz, Carla M. T. Bauer, Gordon J. Gaschler, Katie Fraser, Robert M. Strieter, Cory M. Hogaboam, Martin R. Stämpfli · 2010 · The Journal of Immunology
19. Time-Dependent Increase in Susceptibility and Severity of Secondary Bacterial Infections During SARS-CoV-2
    Amanda Pfaff Smith, Evan Peter Williams, Taylor R. Plunkett, Muneeswaran Selvaraj, Lindey C. Lane, Lillian Zalduondo, Yi Xue, Peter Vogel, Rudragouda Channappanavar, Colleen Beth Jonsson et al. · 2022 · Frontiers in Immunology
20. The changing spectrum of microbial aetiology of respiratory tract infections in hospitalized patients before and during the COVID-19 pandemic
    Sondre Serigstad, Dagfinn Lunde Markussen, Christian Ritz et al. · 2022 · BMC Infectious Diseases
21. Bacterial and fungal superinfections are detected at higher frequency in critically ill patients affected by SARS CoV‐2 infection than negative patients and are associated to a worse outcome
    Maria Antonia De Francesco, Liana Signorini, Simone Piva, Simone Pellizzeri, Benedetta Fumarola, Silvia Corbellini, Giorgio Piccinelli, Francesca Simonetti, Valentina Carta, Lucia Mangeri et al. · 2023 · Journal of Medical Virology
22. Public health and economic impact of vaccination with 7-valent pneumococcal vaccine (PCV7) in the context of the annual influenza epidemic and a severe influenza pandemic
    Jaime L. Rubin, Lisa J. McGarry, Keith P. Klugman, David R. Strutton, Kristen E. Gilmore, Milton C. Weinstein · 2010 · BMC Infectious Diseases
23. Inactivated Influenza Vaccines for Prevention of Community-Acquired Pneumonia
    Jill M. Ferdinands, Paul M. Gargiullo, Michael Haber, Matthew R. Moore, Edward A. Belongia, David K. Shay · 2013 · Epidemiology
24. Influenza vaccines to control influenza-associated bacterial infection: where do we stand?
    Ioanna Christopoulou, Kenny Roose, Lorena Itatí Ibañez, Xavier Saelens · 2014 · Expert Review of Vaccines
25. Influenza, evolution, and the next pandemic
    David S. Fedson · 2018 · Evolution Medicine and Public Health
26. Pneumococcal and Influenza Vaccination Rates and Pneumococcal Invasive Disease Rates Set Geographical and Ethnic Population Susceptibility to Serious COVID-19 Cases and Deaths
    Robert Scott Root-Bernstein · 2021 · Vaccines
27. Estimating the prevalence of coinfection with influenza virus and the atypical bacteria Bordetella pertussis, Chlamydophila pneumoniae, and Mycoplasma pneumoniae
    Michael Joseph Mina, Rachel M. Burke, Keith P. Klugman · 2014 · European Journal of Clinical Microbiology & Infectious Diseases
28. Streptococcus pyogenes
    Amy Evelyn Bryant, Dennis Leroy Stevens · 2015 · Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
29. 2008–2009 Influenza update: A better vaccine match
    Sherif Beniameen Mossad · 2008 · Cleveland Clinic Journal of Medicine
30. PPARα exacerbates necroptosis, leading to increased mortality in postinfluenza bacterial superinfection
    Vincent C. Tam, Rosa Suen, Piper M. Treuting, Aaron M. Armando, Ronald Lucarelli, Norma Gorrochótegui-Escalante, Alan H. Diercks, Oswald Quehenberger, Edward A. Dennis, Alan A. Aderem et al. · 2020 · Proceedings of the National Academy of Sciences
31. Metaproteomics Analysis of SARS-CoV-2-Infected Patient Samples Reveals Presence of Potential Coinfecting Microorganisms
    Peter S. Thuy-Boun, Subina Mehta, Bjoern Gruening, Thomas F. McGowan, An Nguyen, Andrew T. Rajczewski, James E. Johnson, Timothy J. Griffin, Dennis W. Wolan, Pratik Dilip Jagtap · 2021 · Journal of Proteome Research
32. Super Dominant Pathobiontic Bacteria in the Nasopharyngeal Microbiota Cause Secondary Bacterial Infection in COVID-19 Patients
    Tian Qin, Yajie Wang, Jianping Deng, Baohong Xu, Xiong Zhu, Jitao Wang, Haijian Zhou, Na Zhao, Fangfang Jin, Hongyu Ren et al. · 2022 · Microbiology Spectrum
33. Cysteinyl Maresins Reprogram Macrophages to Protect Mice from Streptococcus pneumoniae after Influenza A Virus Infection
    Luciana P. Tavares, Thayse R. Brüggemann, Rafael Machado Rezende, Marina Machado, Rebecca Elaine Cagnina, Ashley Elizabeth Shay, Cristiana Couto Garcia, Julie Nijmeh, Mauro Martins Teixeira, Bruce David Levy · 2022 · mBio
34. Association of Upper Respiratory Streptococcus pneumoniae Colonization With Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Adults
    Anna M. Parker, Nicole C. Jackson, Shevya Awasthi, Han‐Na Kim, Tess Alwan, Anne L. Wyllie, Alisha B. Baldwin, Nicole B. Brennick, Erica A. Moehle, Petros Giannikopoulos et al. · 2022 · Clinical Infectious Diseases
35. PI3K/AKT-mediated autophagy inhibition facilitates mast cell activation to enhance severe inflammatory lung injury in influenza A virus- and secondary Staphylococcus aureus-infected mice
    Yuling Tang, Ruijing Su, Qingyue Gu, Yanxin Hu, Hanchun Yang · 2022 · Antiviral Research
36. Vaccination against Community-Acquired Pneumonia in Spanish Adults: Practical Recommendations by the NeumoExperts Prevention Group
    Esther Redondo, Irene Rivero Calle, Enrique Mascarós, Daniel Ocaña, Isabel Jimeno, Ángel Gil de Miguel, J. L. Díaz-Maroto, Manuel Linares, Maria Ángeles Onieva-García, Fernando González‐Romo et al. · 2023 · Antibiotics
37. The complication of coinfection.
    Lesley Pasman · 2012 · Europe PMC (PubMed Central)
38. Increased mortality of solid organ transplant recipients with H1N1 infection: a single center experience
    Sarah Marie Gainer, Samir J. Patel, Harish Seethamraju · 2011 · Clinical Transplantation
39. The Anticipated Severity of a “1918-Like” Influenza Pandemic in Contemporary Populations: The Contribution of Antibacterial Interventions
    Yu‐Wen Chien, Bruce R. Levin, Keith P. Klugman · 2012 · PLoS ONE
40. Zoonotic Ecosyndemics and Multispecies Ethnography
    Merrill C. Singer · 2014 · Anthropological Quarterly
41. Aerosol and nasal delivery of vaccines and antiviral drugs against seasonal and pandemic influenza
    Jonathan P. Wong, Mary E. Christopher, Satya Viswanathan, Glen Schnell, Xiaojiang Dai, Donald Van Loon, Eric R Stephen · 2010 · Expert Review of Respiratory Medicine
42. Clinical relevance of mixed respiratory viral infections in adults with influenza A H1N1: Table 1–
    María Ángeles Marcos, Santiago Ramón y Cajal, Andrés Antón · 2011 · European Respiratory Journal
43. Interleukin-35 is upregulated in response to influenza virus infection and secondary bacterial pneumonia
    Yi Chen, Chuanjiang Wang, Shihui Lin, Mu Zhang, Sheng-yuan Li, Fang Xu · 2016 · Cytokine
44. Effectiveness of 23-valent pneumococcal polysaccharide vaccination in preventing community-acquired pneumonia hospitalization and severe outcomes in the elderly in Spain
    Ángela Domı́nguez, Núria Soldevila, Diana Toledo et al. · 2017 · PLoS ONE
45. The θ-defensin retrocyclin 101 inhibits TLR4- and TLR2-dependent signaling and protects mice against influenza infection
    Daniel Prantner, Kari Ann Shirey, Wendy Lai, Wuyuan Lu, Alexander M. Cole, Stefanie N. Vogel, Alfredo Garzino Demo · 2017 · Journal of Leukocyte Biology
46. The influenza of 1918
    Margaret Humphreys · 2018 · Evolution Medicine and Public Health
47. Estimating age-stratified influenza-associated invasive pneumococcal disease in England: A time-series model based on population surveillance data
    Chiara Chiavenna, Anne Margaret Presanis, André Charlett, Simon de Lusignan, Shamez N Ladhani, Richard G. Pebody, Daniela De Angelis · 2019 · PLoS Medicine
48. The Nontypeable Haemophilus influenzae Major Adhesin Hia Is a Dual-Function Lectin That Binds to Human-Specific Respiratory Tract Sialic Acid Glycan Receptors
    John M. Atack, Christopher J. Day, Jessica Poole · 2020 · mBio
49. Endotoxin Adsorbent Therapy in Severe COVID-19 Pneumonia
    Sadudee Peerapornratana, Phatadon Sirivongrangson, Somkanya Tungsanga, Kanitha Tiankanon, Win Kulvichit, Opass Putcharoen, John A. Kellum, Nattachai Srisawat · 2021 · Blood Purification
50. Understanding Influenza
    Edward C. Hutchinson, Yohei Yamauchi · 2018 · Methods in molecular biology
51. Effect of Vitamin A Deficiency in Dysregulating Immune Responses to Influenza Virus and Increasing Mortality Rates After Bacterial Coinfections
    Rhiannon R. Penkert, Amanda Pfaff Smith, Eike Roman Hrincius, Jonathan A. McCullers, Peter Vogel, Amber M. Smith, Julia L. Hurwitz · 2020 · The Journal of Infectious Diseases
52. Sequential targeting of interferon pathways for increased host resistance to bacterial superinfection during influenza
    Tarani Kanta Barman, Rachael Racine, Jesse L. Bonin, Danielle Califano, Sharon L. Salmon, Dennis W. Metzger · 2021 · PLoS Pathogens
53. Learning From Mistakes: The Role of Phages in Pandemics
    Ahlam Alsaadi, Beatriz Beamud, Maheswaran Easwaran, Fatma Ibrahim Abdelrahman, Ayman El‐Shibiny, Majed F. Alghoribi, Pilar Domingo‐Calap · 2021 · Frontiers in Microbiology
54. RNA thermosensors facilitate Streptococcus pneumoniae and Haemophilus influenzae immune evasion
    Hannes Eichner, Jens Karlsson, Laura Spelmink · 2021 · PLoS Pathogens
55. The indirect impact of COVID-19 large-scale containment measures on the incidence of community-acquired pneumonia in older people: a region-wide population-based study in Tuscany, Italy
    Vieri Lastrucci, Guglielmo Bonaccorsi, Silvia Forni · 2021 · International Journal of Infectious Diseases
56. Secondary infection with Streptococcus pneumoniae decreases influenza virus replication and is linked to severe disease
    Karina Mueller Brown, Valerie Le Sage, Andrea J. French, Jennifer E. Jones, Gabriella H. Padovani, Annika J. Avery, Michael M. Myerburg, Stacey Schultz‐Cherry, Jason W. Rosch, Natalia Luisa Hiller et al. · 2022 · FEMS Microbes
57. A machine learning framework for identifying influenza pneumonia from bacterial pneumonia for medical decision making
    Qian Zhang, Anran Huang, Lianyou Shao, Peiliang Wu, Ali Asghar Heidari, Zhennao Cai, Guoxi Liang, Huiling Chen, Fahd Saleh Alotaibi, Majdi M. Mafarja et al. · 2022 · Journal of Computational Science
58. Epidemiology of bacterial co-infections and risk factors in COVID-19-hospitalized patients in Spain: a nationwide study
    Rocío López-Herrero, Laura Sánchez-de Prada, Álvaro Tamayo-Velasco, Mario Lorenzo‐López, Estefanía Gómez‐Pesquera, Belén Sánchez-Quirós, Olga de la Varga-Martínez, E. Gómez-Sánchez, Salvador Resino, Eduardo Tamayo et al. · 2023 · European Journal of Public Health
59. Molecular Imaging of Influenza and Other Emerging Respiratory Viral Infections
    Mike Bray, James V. Lawler, Jason Paragas, Peter B. Jahrling, Daniel J. Mollura · 2011 · The Journal of Infectious Diseases
60. Transcriptional adaptation of pneumococci and human pharyngeal cells in the presence of a virus infection
    Sheila Z. Kimaro Mlacha, Teresa C. T. Peret, Nikhil Kumar, Sandra Romero‐Steiner, Julie C. Dunning Hotopp, Nadeeza Ishmael, Valerie Grinblat-Huse, David R. J. Riley, Dean D. Erdman, George M. Carlone et al. · 2013 · BMC Genomics
61. Planning for an Influenza Pandemic: Thinking beyond the Virus
    Jonathan A. McCullers · 2008 · The Journal of Infectious Diseases
62. Influenza-associated bacterial pneumonia; managing and controlling infection on two fronts
    Aaron J. Campigotto, Samira Mubareka · 2014 · Expert Review of Anti-infective Therapy
63. Influenza A and methicillin-resistant Staphylococcus aureus co-infection in rhesus macaques – A model of severe pneumonia
    Daniel S. Chertow, Jason Kindrachuk, Zong‐Mei Sheng, Lindsey M. Pujanauski, Kurt Cooper, Daniel Nogee, Marisa St. Claire, Jeffrey M. Solomon, Donna L. Perry, Philip J. Sayre et al. · 2016 · Antiviral Research
64. Innate (General or Nonspecific) Host Defense Mechanisms
    Carl W. Dieffenbach, Edmund C. Tramont · 2015 · Elsevier eBooks
65. Exogenous Activation of Invariant Natural Killer T Cells by α-Galactosylceramide Reduces Pneumococcal Outgrowth and Dissemination Postinfluenza
    Adeline Barthélémy, Stoyan Ivanov, Maya Hassane, Josette Fontaine, Béatrice Heurtault, Benoı̂t Frisch, Christelle Faveeuw, Christophe Paget, François Trottein · 2016 · mBio
66. Free actin impairs macrophage bacterial defenses via scavenger receptor MARCO interaction with reversal by plasma gelsolin
    Christine M. Ordija, Terry Ting-Yu Chiou, Zhiping Yang, Glen M. DeLoid, Melina de Oliveira Valdo, Zhi Wang, Alice S. Bedugnis, Terry L. Noah, Samuel Jones, Henry Koziel et al. · 2017 · American Journal of Physiology-Lung Cellular and Molecular Physiology
67. Streptococcus pneumoniae
    Edward N. Janoff, Daniel M. Musher · 2015 · Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
68. Adaptive vaccination strategies to mitigate pandemic influenzaMexico as a case study
    Gerardo Chowell, Cecile G. Viboud, Xiaohong Wang · 2009 · PLoS Currents
69. Legionella Infection during and after the COVID-19 Pandemic
    Rafik Dey, Nicholas J. Ashbolt · 2020 · ACS ES&T Water
70. Pneumococcal vaccine in the elderly: a useful but forgotten vaccine
    Christian Chidiac, Florence Ader · 2009 · Aging Clinical and Experimental Research
71. Influenza infection in human host: challenges in making a better influenza vaccine
    Ramandeep Kaur Virk, Vithiagaran Gunalan, Paul Anantharajah Tambyah · 2016 · Expert Review of Anti-infective Therapy
72. Relevance of angiotensin-(1-7) and its receptor Mas in pneumonia caused by influenza virus and post-influenza pneumococcal infection
    Eliza Mathias Melo, Juliana Del Sarto, Juliana P. Vago, Luciana P. Tavares, Flávia Rago, Ana Paula Gonçalves, Marina Machado, Irene Aranda-Pardos, Bruno Vinícius Santos Valiate, Geovanni Dantas Cassali et al. · 2020 · Pharmacological Research
73. COVID-19: an ‘extraterrestrial’ disease?
    Élisabeth Paul, Garrett Wallace Brown, Mélanie Dechamps, Andreas Kalk, Pierre‐François Laterre, Bernard Rentier, Valéry Ridde, Martin Zizi · 2021 · International Journal of Infectious Diseases
74. Procalcitonin Levels in COVID-19 Patients Are Strongly Associated with Mortality and ICU Acceptance in an Underserved, Inner City Population
    Theresa Feng, Alecia James, Kyra Doumlele, Seth White, Wendy Twardzik, Kanza Zahid, Zeeshan Sattar, Osato Ukponmwan, Mohamd Nakeshbandi, Lillian S.N. Chow et al. · 2021 · Medicina
75. Outbreak of Invasive Group A Streptococcus in Children—Colorado, October 2022–April 2023
    Erin C Ho, Jessica R. Cataldi, Lori J. Silveira, Meghan C Birkholz, Michele M. Loi, Christina M. Osborne, Samuel R. Dominguez · 2023 · Journal of the Pediatric Infectious Diseases Society
76. Epidemiological investigation of lower respiratory tract infections during influenza A (H1N1) pdm09 virus pandemic based on targeted next-generation sequencing
    Xiaodan Li, Yang Liu, Minzhe Li, Jing Bian, Demei Song, Chaoying Liu · 2023 · Frontiers in Cellular and Infection Microbiology
77. Reducing the impact of influenza‐associated secondary pneumococcal infections
    Edin Jessica Mifsud, Amabel C. L. Tan, Kirsty Renfree Short, Lorena E. Brown, Brendon Yew Loong Chua, David Charles Jackson · 2015 · Immunology and Cell Biology
78. Linezolid Decreases Susceptibility to Secondary Bacterial Pneumonia Postinfluenza Infection in Mice Through its Effects on IFN-γ
    Jessica M. Deckman, Cynthia A. Mattingly, Susan E. Birket, Samantha Hoskins, Tam N. Ho, Beth A. Garvy, David J. Feola · 2013 · The Journal of Immunology
79. New Wisdom to Defy an Old Enemy: Summary from a scientific symposium at the 4th Influenza Vaccines for the World (IVW) 2012 Congress, 11 October, Valencia, Spain
    Gregory A. Poland, Douglas Fleming, John J. Treanor, Eugene Maraskovsky, Thomas C Luke, Emma M. A. Ball, Caroline M. Poland · 2013 · Vaccine
80. Microbial pathogenesis and type III interferons
    Taylor S. Cohen, Dane Parker · 2016 · Cytokine & Growth Factor Reviews
81. Coinfection, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), and Influenza: An Evolving Puzzle
    Sara E. Covin, George Williams Rutherford · 2020 · Clinical Infectious Diseases
82. Risk Factors for Pneumonia and Death in Adult Patients With Seasonal Influenza and Establishment of Prediction Scores: A Population-Based Study
    Koichi Miyashita, Eiji Nakatani, Hironao Hozumi · 2021 · Open Forum Infectious Diseases
83. The Balance of Neutrophil Extracellular Trap Formation and Nuclease Degradation: an Unknown Role of Bacterial Coinfections in COVID-19 Patients?
    Nicole de Buhr, Maren von Köckritz‐Blickwede · 2021 · mBio
84. Influenza A induced cellular signal transduction pathways.
    Paul Michael, Danielle Brabant, Farag Bleiblo, Chilakamarti V. Ramana, Michael Rutherford, Sandhya Khurana, T C Tai, Anand Kumar, Aseem Kumar · 2013 · Europe PMC (PubMed Central)
85. Modeling the critical care demand and antibiotics resources needed during the Fall 2009 wave of influenza A(H1N1) pandemic
    Duygu Balcan, Vittoria Colizza A, Andrew C. Singer, CHRISTOS CHOUAID, Hao Hu, Bruno Gonçalves, Paolo Bajardi, Chiara Poletto, José J. Ramasco, Nicola Perra et al. · 2009 · PLoS Currents
86. 1918 Influenza, a Puzzle with Missing Pieces
    David Michael Morens, Jeffery K. Taubenberger · 2012 · Emerging infectious diseases
87. Vaccination against the M protein of Streptococcus pyogenes prevents death after influenza virus:S. pyogenes super-infection
    Joshua M. Klonoski, Heather R. Hurtig, Brian A. Juber, Margaret J. Schuneman, Thomas E. Bickett, Joshua M. Svendsen, Brandon Burum, Thomas A. Penfound, Grigoriy A. Sereda, James B. Dale et al. · 2014 · Vaccine
88. Co-colonization by<i>Streptococcus pneumoniae</i>and<i>Staphylococcus aureus</i>in the throat during acute respiratory illnesses
    DE LASTOURS, V., MALOSH, R., RAMADUGU, K., SRINIVASAN, U., DAWID, S., OHMIT, S., FOXMAN, B. · 2016 · Epidemiology and Infection
89. Viral Coinfection Replaces Effects of Suilysin on Streptococcus suis Adherence to and Invasion of Respiratory Epithelial Cells Grown under Air-Liquid Interface Conditions
    Fandan Meng, Jie Tong, Désirée Vötsch, Ju-Yi Peng, Xuehui Cai, Maren Willenborg, Georg Herrler, Nai‐Huei Wu, Peter Valentin‐Weigand · 2019 · Infection and Immunity
90. Bacterial superinfection pneumonia in SARS-CoV-2 respiratory failure
    Chiagozie Ifeoma Pickens, Catherine A. Gao, Michael J. Cuttica, Sean B. Smith, Lorenzo L. Pesce, Rogan A. Grant, Mengjia Kang, Luisa Morales‐Nebreda, Avni A. Bavishi, Jason M Arnold et al. · 2021 · medRxiv
91. Impaired immune signaling and changes in the lung microbiome precede secondary bacterial pneumonia in COVID-19
    Alexandra Tsitsiklis, Beth Shoshana Zha, Ashley Byrne, Catherine DeVoe, Elze Rackaityte, Sophia Levan, Sara Sunshine, Eran Mick, Rajani Ghale, Christina Love et al. · 2021 · medRxiv
92. Temporal cross‐correlation between influenza‐like illnesses and invasive pneumococcal disease in The Netherlands
    Wilke Hendriks, Hendriek C. Boshuizen, Arnold L. M. Dekkers, Mirjam J. Knol, Gé Donker, Arie VAN DER ENDE, Hester Korthals Altes · 2016 · Influenza and Other Respiratory Viruses
93. Exposing the Two Contrasting Faces of STAT2 in Inflammation
    Philip Duodu, Geohaira Sosa, Jorge Canar, Olivia Chhugani, Ana M. Gamero · 2022 · Journal of Interferon & Cytokine Research
94. Targeting complement hyperactivation: a novel therapeutic approach for severe pneumonia induced by influenza virus/staphylococcus aureus coinfection
    Leili Jia, Haihua Luo, Lizhong Li, Mingyao Wang, Jiangfeng Liu, Yuan Liang, Shan Li, Yong Jiang, Juntao Yang, Hongbin Song · 2023 · Signal Transduction and Targeted Therapy
95. Light‐Assisted 3D‐Printed Hydrogels for Antibacterial Applications
    Liwen Zhang, Naufal Kabir Ahamed Nasar, Xumin Huang, Chenyang Hu, Xuan Pang, Xuesi Chen, Ruirui Qiao, Thomas Paul Davis · 2024 · Small Science
96. Influenza A virus‐mediated priming enhances cytokine secretion by human dendritic cells infected with S treptococcus pneumoniae
    Thomas Kuri, Anna Smed‐Sörensen, Saskia Thomas, Gunilla B. Karlsson Hedestam, Staffan J. Normark, Birgitta Henriques‐Normark, Gerald M. McInerney, Laura Plant · 2013 · Cellular Microbiology
97. Models cannot predict future outbreaks: A/H1N1 virus, the paradigm
    Antoine Nougaırède, Rémi N. Charrel, Didier Raoult · 2010 · European Journal of Epidemiology
98. TLR7 Contributes to the Rapid Progression but Not to the Overall Fatal Outcome of Secondary Pneumococcal Disease following Influenza A Virus Infection
    Sabine Stegemann‐Koniszewski, Marcus Gereke, Sofia Orrskog, Stefan Lienenklaus, Bastian Pasche, Sophie R. Bader, Achim Dieter Gruber, Shizuo Akira, Siegfried Weiß, Birgitta Henriques‐Normark et al. · 2012 · Journal of Innate Immunity
99. Invasive Pneumococcal Disease and Pandemic (H1N1) 2009, Denver, Colorado, USA
    George E. Nelson, Kenneth A. Gershman, David L. Swerdlow, Bernard Beall, Matthew R. Moore · 2012 · Emerging infectious diseases
100. Hemagglutinin from the H5N1 Virus Activates Janus Kinase 3 to Dysregulate Innate Immunity
     Wei Xu, Minhui Chen, Nanhai Ge, Jun Xu · 2012 · PLoS ONE